| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2016-09-08 10:02:43 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm will hold Second Quarter 2016 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 12, 2016 at 16:00 (EEST). Please note that attendees have to register for the webinar in advance – detailed information on the registration process is available below. Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” activities and financial results of second quarter of 2016. After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till September 11 to e-mail: ieva.unda@nasdaq.com.
Registration process You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds. What is a
corporate webinar?
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia. Information
prepared by: |
| Pielikumi |
|